• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从因果关系角度重新定义样本的代表性。

Redefining Representativeness of a Sample in Causal Terms.

作者信息

Sikorski Michał, Gebharter Alexander, Osimani Barbara

机构信息

Center for Philosophy, Science, and Policy, Marche Polytechnic University, Ancona, Italy.

出版信息

J Eval Clin Pract. 2025 Jun;31(4):e70137. doi: 10.1111/jep.70137.

DOI:10.1111/jep.70137
PMID:40545908
Abstract

RATIONALE

Despite its crucial role, sample representativeness remains a controversial topic in the methodology of medical science. There is an ongoing debate not only about how best to define and ensure the representativeness of a sample (e.g., Rudolph et al. 2023; Porta 2016), but also about whether representativeness is worth pursuing at all (e.g., Rothman et al. 2013).

AIMS AND OBJECTIVES

Our aim is to construct a formalised, precise, and practical conceptualisation of sample representativeness.

METHODS

We employ the established framework of causal Bayesian networks to develop such a conceptualisation.

RESULTS

We propose a precise formal definition of sample representativeness that translates into clear and actionable methodological guidance. Additionally, we provide examples and a checklist to illustrate the application of the proposed conceptualisation.

CONCLUSION

We believe that the presented definition will facilitate further discussion of the issue of representativeness and prove useful to scientists in practice.

摘要

理论依据

尽管样本代表性起着关键作用,但在医学科学方法论中,它仍是一个有争议的话题。目前不仅存在关于如何最好地定义和确保样本代表性的争论(例如,鲁道夫等人,2023年;波尔塔,2016年),还存在关于代表性是否值得追求的争论(例如,罗斯曼等人,2013年)。

目的

我们的目标是构建一个形式化、精确且实用的样本代表性概念。

方法

我们采用因果贝叶斯网络的既定框架来发展这样一个概念。

结果

我们提出了样本代表性的精确形式定义,该定义转化为清晰且可操作的方法指导。此外,我们提供了示例和清单来说明所提出概念的应用。

结论

我们相信所提出的定义将促进对代表性问题的进一步讨论,并在实践中对科学家有用。

相似文献

1
Redefining Representativeness of a Sample in Causal Terms.从因果关系角度重新定义样本的代表性。
J Eval Clin Pract. 2025 Jun;31(4):e70137. doi: 10.1111/jep.70137.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
5
Incentives for preventing smoking in children and adolescents.预防儿童和青少年吸烟的激励措施。
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3.
6
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
7
Interventions for preventing and reducing the use of physical restraints of older people in general hospital settings.预防和减少一般医院环境中老年人身体约束使用的干预措施。
Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD012476. doi: 10.1002/14651858.CD012476.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
10
Face-to-face interventions for informing or educating parents about early childhood vaccination.针对向父母宣传或教育幼儿疫苗接种情况的面对面干预措施。
Cochrane Database Syst Rev. 2018 May 8;5(5):CD010038. doi: 10.1002/14651858.CD010038.pub3.

本文引用的文献

1
Variable selection when estimating effects in external target populations.在外部目标人群中估计效应时的变量选择。
Am J Epidemiol. 2024 Aug 5;193(8):1176-1181. doi: 10.1093/aje/kwae048.
2
Defining representativeness of study samples in medical and population health research.界定医学与人群健康研究中样本的代表性。
BMJ Med. 2023 May 16;2(1):e000399. doi: 10.1136/bmjmed-2022-000399. eCollection 2023.
3
Evidence-based Medicine and Mechanistic Evidence: The Case of the Failed Rollout of Efavirenz in Zimbabwe.循证医学与机制证据:津巴布韦失败推出依非韦伦的案例。
J Med Philos. 2023 Jun 20;48(4):348-358. doi: 10.1093/jmp/jhad019.
4
Neuropeptidergic regulation of compulsive ethanol seeking in C. elegans.神经肽对秀丽隐杆线虫强迫性乙醇觅药行为的调节。
Sci Rep. 2022 Feb 2;12(1):1804. doi: 10.1038/s41598-022-05256-1.
5
Conceptual spaces and the strength of similarity-based arguments.概念空间与基于相似性论证的强度。
Cognition. 2022 Jan;218:104951. doi: 10.1016/j.cognition.2021.104951. Epub 2021 Nov 19.
6
Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations.应用健康研究中使用有向无环图(DAG)识别混杂因素:综述与建议。
Int J Epidemiol. 2021 May 17;50(2):620-632. doi: 10.1093/ije/dyaa213.
7
Directed Acyclic Graphs, Effect Measure Modification, and Generalizability.有向无环图、效应修正和可推广性。
Am J Epidemiol. 2021 Feb 1;190(2):322-327. doi: 10.1093/aje/kwaa185.
8
Rolling out Efavirenz for HIV Precision Medicine in Africa: Are We Ready for Pharmacovigilance and Tackling Neuropsychiatric Adverse Effects?在非洲推广依非韦伦用于HIV精准医学:我们是否已准备好开展药物警戒并应对神经精神不良反应?
OMICS. 2016 Oct;20(10):575-580. doi: 10.1089/omi.2016.0120. Epub 2016 Sep 14.
9
Why have clinical trials in sepsis failed?为什么脓毒症临床试验会失败?
Trends Mol Med. 2014 Apr;20(4):195-203. doi: 10.1016/j.molmed.2014.01.007. Epub 2014 Feb 24.
10
Commentary: Representativeness is usually not necessary and often should be avoided.评论:代表性通常并非必要,而且往往应予以避免。
Int J Epidemiol. 2013 Aug;42(4):1018-22. doi: 10.1093/ije/dyt103.